<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: <z:mp ids='MP_0001625'>Cardiac hypertrophy</z:mp> and <z:hpo ids='HP_0001635'>heart failure</z:hpo> are associated with QT prolongation and lethal <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> resulting from decreased <z:chebi fb="0" ids="29103">K(+)</z:chebi> current densities and impaired repolarization </plain></SENT>
<SENT sid="1" pm="."><plain>Recent studies in mouse models of physiological <z:mp ids='MP_0001625'>cardiac hypertrophy</z:mp> revealed that increased <z:chebi fb="0" ids="16749">phosphoinositide</z:chebi>-3-kinase-α (PI3Kα) signalling results in the up-regulation of <z:chebi fb="0" ids="29103">K(+)</z:chebi> channels and the normalization of ventricular repolarization </plain></SENT>
<SENT sid="2" pm="."><plain>The experiments here were undertaken to test the hypothesis that increased PI3Kα signalling will counteract the adverse electrophysiological remodelling associated with pathological <z:mpath ids='MPATH_159'>hypertrophy</z:mpath> and <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS AND RESULTS: In contrast to <z:mp ids='MP_0002169'>wild-type</z:mp> mice, left ventricular (LV) <z:mpath ids='MPATH_159'>hypertrophy</z:mpath>, induced by transverse aortic constriction (<z:chebi fb="44" ids="53498">TAC</z:chebi>), did not result in prolongation of ventricular action potentials or QT intervals in mice with cardiac-specific expression of constitutively active PI3Kα (caPI3Kα) </plain></SENT>
<SENT sid="4" pm="."><plain>Indeed, repolarizing <z:chebi fb="0" ids="29103">K(+)</z:chebi> currents and <z:chebi fb="0" ids="29103">K(+)</z:chebi> channel subunit transcripts were increased in caPI3Kα + <z:chebi fb="44" ids="53498">TAC</z:chebi> LV myocytes in proportion to the <z:chebi fb="44" ids="53498">TAC</z:chebi>-induced <z:mp ids='MP_0005482'>cellular hypertrophy</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0001635'>Congestive heart failure</z:hpo> in a <z:e sem="disease" ids="C1519606" disease_type="Experimental Model of Disease" abbrv="">transgenic model</z:e> of <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo> model is accompanied by <z:mp ids='MP_0003233'>prolonged QT intervals</z:mp> and ventricular action potentials, reduced <z:chebi fb="0" ids="29103">K(+)</z:chebi> currents and <z:chebi fb="0" ids="29103">K(+)</z:chebi> channel transcripts </plain></SENT>
<SENT sid="6" pm="."><plain>Increased PI3Kα signalling, but not renin-angiotensin system blockade, in this model also results in increased <z:chebi fb="0" ids="29103">K(+)</z:chebi> currents and improved ventricular repolarization </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: In the setting of pathological <z:mpath ids='MPATH_159'>hypertrophy</z:mpath> or <z:hpo ids='HP_0001635'>heart failure</z:hpo>, enhanced PI3Kα signalling results in the up-regulation of <z:chebi fb="0" ids="29103">K(+)</z:chebi> channel subunits, normalization of <z:chebi fb="0" ids="29103">K(+)</z:chebi> current densities and preserved ventricular function </plain></SENT>
<SENT sid="8" pm="."><plain>Augmentation of PI3Kα signalling, therefore, may be a useful and unique strategy to protect against the increased risk of <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> and <z:hpo ids='HP_0001699'>sudden death</z:hpo> associated with <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> </plain></SENT>
</text></document>